IMMUNOGENICITY OF INTRAVENOUS ASPARAGINASE ERWINIA CHRYSANTHEMI IN PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA

被引：0
|
作者：
Benson, B. [1 ]
Lu, Y. [2 ]
Eller, M. [3 ]
机构：
[1] Jazz Pharmaceut Inc, Clincial Dev, Palo Alto, CA USA
[2] Jazz Pharmaceut Inc, Biostat, Palo Alto, CA USA
[3] Jazz Pharmaceut Inc, Res & Clin Dev, Palo Alto, CA USA
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-037
引用
收藏
页码：S262 / S262
页数：1
相关论文
共 50 条
  • [1] Asparaginase Erwinia chrysanthemi-rywn for the treatment of acute lymphoblastic leukemia and lymphoblastic lymphoma
    Gao, Congying
    Ma, Xiangyu
    Zhang, Zifan
    Lu, Qisi
    Ashby, Charles R.
    Wei, Liuya
    Chen, Zhe-Sheng
    DRUGS OF TODAY, 2022, 58 (06) : 261 - 271
  • [2] Development of asparaginase Erwinia chrysanthemi for the treatment of acute lymphoblastic leukemia
    Salzer, Wanda L.
    Asselin, Barbara L.
    Plourde, Paul V.
    Corn, Tim
    Hunger, Stephen P.
    PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALISTS FOR THE PRIX GALIEN USA AWARDS 2013, 2014, 1329 : 81 - 92
  • [3] Immunogenicity of Recombinant Erwinia asparaginase (JZP458) for Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
    Maese, Luke
    Loh, Mignon L.
    Choi, Mi Rim
    Liang, Yali
    Aoki, Etsuko
    Roller, Shane
    Lin, Tong
    Agarwal, Shirali
    Chandrasekaran, Vijayalakshmi
    Iannone, Robert
    Silverman, Lewis B.
    Raetz, Elizabeth A.
    Rau, Rachel E.
    BLOOD, 2023, 142
  • [4] Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients
    Sassen, Sebastiaan D. T.
    Mathot, Ron A. A.
    Pieters, Rob
    Kloos, Robin Q. H.
    de Haas, Valerie
    Kaspers, Gertjan J. L.
    van den Bos, Cor
    Tissing, Wim J. E.
    te Loo, Maroeska
    Bierings, Marc B.
    Kollen, Wouter J. W.
    Zwaan, Christian M.
    van der Sluis, Inge M.
    HAEMATOLOGICA, 2017, 102 (03) : 552 - 561
  • [5] Asparaginase Erwinia chrysanthemi (Erwinaze®): A Guide to Its Use in Acute Lymphoblastic Leukemia in the USA
    Keating, Gillian M.
    BIODRUGS, 2013, 27 (04) : 413 - 418
  • [6] Asparaginase Erwinia chrysanthemi (Erwinaze®): A Guide to Its Use in Acute Lymphoblastic Leukemia in the USA
    Gillian M. Keating
    BioDrugs, 2013, 27 : 413 - 418
  • [7] Erwinia asparaginase in pediatric acute lymphoblastic leukemia
    Salzer, Wanda
    Seibel, Nita
    Smith, Malcolm
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (10) : 1407 - 1414
  • [8] Population pharmacokinetics of intramuscular recombinant Erwinia chrysanthemi asparaginase (JZP458) in patients with acute lymphoblastic leukemia
    Lin, Tong
    Whigham, Tajhia
    Fernando, Indrasiri
    Choi, Mi Rim
    Wang, Qi
    Silverman, Jeffrey A.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (05): : 898 - 909
  • [9] Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
    Maese, Luke
    Rau, Rachel E.
    FRONTIERS IN PEDIATRICS, 2022, 10
  • [10] The use of Erwinia asparaginase for adult patients with acute lymphoblastic leukemia after pegaspargase intolerance
    Horvat, Troy Z.
    Pecoraro, Joshua J.
    Daley, Ryan J.
    Buie, Larry W.
    King, Amber C.
    Rampal, Raajit K.
    Tallman, Martin S.
    Park, Jae H.
    Douer, Dan
    LEUKEMIA RESEARCH, 2016, 50 : 17 - 20
12345